Preethy
Active Director Director DIN 07034560
DIN 07034560 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Preethy

Data last updated:

Preethy is a Director at Nichi-In Bio-Sciences Private Limited (since 2018). The company operates in Pharma. Nichi-In Bio-Sciences Private Limited reported revenue of ₹22.8 Lakh (FY 2025).

DIN 07034560
Primary Designation Director
Industry Pharma
First Appointment 23 May 2018
Oldest Company Age 26 yrs
Largest company Nichi-In Bio-Sciences Private Limited · ₹22.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20182000₹22.8 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Nichi-In Bio-Sciences Private Limited
Premium access

Shareholding and investment profile for Preethy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preethy

Preethy currently holds 1 directorship: Nichi-In Bio-Sciences Private Limited (Director, since 23 May 2018, revenue ₹22.8 Lakh (FY 2025)).

Preethy was first appointed on 23 May 2018 as Director at Nichi-In Bio-Sciences Private Limited.

The current boards of Preethy's companies include Josephine Mary Asantha (Nichi-In Bio-Sciences Private Limited), Rajappa Senthil Kumar (Nichi-In Bio-Sciences Private Limited), Valan Anto Raj Michael (Nichi-In Bio-Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available